Table 2.

Sensitivity analysis.

Outcomes	Studies	EG	CG	MD		P-value	Study heterogeneity
	no.	no.	no.	(95% CI)				df	I2, %	P-value
SECONDARY OUTCOMES
BMD	5	201	166	0.03	0.08	<0.001	1.3	3	0	0.73
MMP-3	4	199	193	−11.43	−10.5	<0.0001	5090.63	4	100	<0.00001

Experimental: the group of Chinese Medicines; Control: the group of Western Medicines; CI, confidence interval.